The Riskguard test is a multi-cancer multigene panel that provides a report on variants in genes that are actionable and are included in an easy-to-understand report with potential care options to support treatment discussions.
Cancer:
Breast Cancer, Colorectal Cancer, Endocrine Cancer, Endometrial Cancer, Gastric Cancer, Kidney Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer